Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis

NCT: NCT07662941 · COMPLETED

NCT IDNCT07662941
StatusCOMPLETED
Start Date2024-12-26
Completion2025-12-26
SponsorAnkara Yildirim Beyazıt University (OTHER)
First posted
Last updated

Brief Summary

Plantar fasciitis is one of the most common causes of heel pain and may lead to pain, decreased foot function, impaired balance, and reduced quality of life. Extracorporeal shock wave therapy and exercise therapy are commonly used conservative treatment approaches. This randomized controlled study aims to investigate the additional effects of neural gliding exercises when combined with extracorporeal shock wave therapy and standard exercise treatment in individuals with plantar fasciitis.

Frequently Asked Questions

What is Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis?

Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis is a clinical trial registered under NCT07662941. Current status: COMPLETED.

What is the status of NCT07662941?

The current status of NCT07662941 (Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis) is: COMPLETED.

When did Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis start?

Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis started on 2024-12-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.